Visterra, Inc.
Part of ABX Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GMBH
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
Radeberg, SN
LAHNMPWWFFJ9
-
Parent
Radeberg, SN
LAHNMPWWFFJ9
- SAM.gov registration date
- Website
- visterrainc.com
- Founded
- 2008
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A library of immunoaffinity reagents for RNA modifications | National Institutes of Health | $149,990 |
Quick answers
Is Visterra, Inc. registered in SAM.gov?
Visterra, Inc.'s SAM.gov registration expired on March 3, 2022.
What is Visterra, Inc.'s CAGE code?
Visterra, Inc.'s CAGE code is 6G8T0, and its Unique Entity ID (UEI) is WE1TB9L41Q75.
What is Visterra, Inc.'s most recent federal award?
Visterra, Inc.'s most recent federal grant award is A library of immunoaffinity reagents for RNA modifications (R43DA042466), from National Institutes of Health, on September 1, 2016.
On GovTribe
See Visterra, Inc.'s full federal record
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors